Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast Cancer
暂无分享,去创建一个
N. Harbeck | O. Gluz | S. Kuemmel | C. Liedtke | H. Kreipe | R. Kates | R. Wuerstlein | H. Forstbauer | C. Schumacher | M. Braun | B. Aktas | J. Potenberg | W. Malter | D. Augustin | J. Tio | R. Deurloo | R. von Schumann | C. Biehl | S. de Haas | E. Grischke